SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-058331
Filing Date
2023-07-20
Accepted
2023-07-20 08:56:52
Documents
15
Period of Report
2023-07-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea182059-8k_pasithea.htm   iXBRL 8-K 29116
2 PRESS RELEASE OF PASITHEA THERAPEUTICS CORP. ISSUED JULY 20, 2023 ea182059ex99-1_pasithea.htm EX-99.1 12851
3 GRAPHIC ex99-1_001.jpg GRAPHIC 6279
  Complete submission text file 0001213900-23-058331.txt   274217

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ktta-20230720.xsd EX-101.SCH 3810
5 XBRL DEFINITION FILE ktta-20230720_def.xml EX-101.DEF 26681
6 XBRL LABEL FILE ktta-20230720_lab.xml EX-101.LAB 36819
7 XBRL PRESENTATION FILE ktta-20230720_pre.xml EX-101.PRE 25305
9 EXTRACTED XBRL INSTANCE DOCUMENT ea182059-8k_pasithea_htm.xml XML 5432
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40804 | Film No.: 231098244
SIC: 2834 Pharmaceutical Preparations